Ezetimibe Plus Simvastatin More Beneficial Than Simvastatin Alone in Reducing Recurrent Cardiovascular Events

Article Figures & Data

Figures

  • Figure 1.

    Fewer Total (First and Recurrent) Primary End Point Events With Combination Therapy

    Reproduced with permission from SA Murphy, MPH.

  • Figure 2.

    Risk Differences for Total Primary End Point Events

    CV, cardiovascular; MI, myocardial infarction; NF, nonfatal; Revasc, revascularization; UA, unstable angina.

    *P < .05; others not significant.

    Reproduced with permission from SA Murphy, MPH.